<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-vaccines-08-00273">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lauring</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>J.O.</given-names>
   </name>
   <name>
    <surname>Andino</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Rationalizing the development of live attenuated virus vaccines</article-title>
  <source>Nat. Biotechnol.</source>
  <year>2010</year>
  <volume>28</volume>
  <fpage>573</fpage>
  <lpage>579</lpage>
  <pub-id pub-id-type="doi">10.1038/nbt.1635</pub-id>
  <pub-id pub-id-type="pmid">20531338</pub-id>
 </element-citation>
</ref>
